Font Size: a A A
Keyword [Pancreatic cancer]
Result: 41 - 60 | Page: 3 of 10
41. Impact Of Growth Hormone On Cell Cycle Kinetics Of Pancreatic Cancer Cells And Significance Of Growth Hormone Receptor-JAK2-STATs In Signaling
42. The Expression Level Of Smad4,Smad6 And Smad7 Gene In Pancreatic Cancer And Their Clinical Implications
43. Plasma Proteomic Study Of Pancreatic Cancer And Assessment Of Candidate Tumor Biomarkers
44. Overexpression Of Annexin 1 In Pancreatic Cancer And Its Clinical Significance
45. Preoperative Staging And Tumor Resectability Assessment Of Pancreatic Cancer: Prospective Study Comparing CDFI, EUS, HCT, And MRI
46. The Radioactivity Resistance Of Pancreatic Cancer Cells
47. 1.Patterns Of K-ras Codon 12 And 13 Mutations Found In Pancreatic Adenocarcinoma Of 30 Chinese Patients And Six Chinese Pancreatic Cancer Cell Lines 2.Detection Of TCR, Immunoglobulin Heavy And Light Chain Monoclonal Rearrangements Of 23 Splenic Lymphomas
48. Induced Drug Resistance And Explored The Changes Of The Activity Of Thioredoxin Reductase In Pancreatic Cancer Cell Line
49. Empirical Study Of Cotransfecting Antisense Oligonucleotide For Treating Human Pancreatic Cancer And Observing With MRI Dynamically
50. The Experimental Research On The Therapy Of Pancreatic Cancer By TK Gene That Activated By Egr-1 Promoter
51. Experimental Studies On The Inhibition Of Pancreatic Cancer By Antisense Heparanase Gene
52. The Study Of Differential Proteomics In Pancreatic Cancer
53. A Research On Integrated Traditional Chinese And Western Medicine For The Treatment Of Advanced Pancreatic Cancer
54. The Study Of Expression And Transcription Of Multidrug Resistance Gene 1 In Pancreatic Cancer
55. Study Of The Effect Of Proteasome Inhibitor Bortezomib On Human Pancreatic Cancer Cells
56. In Vitro Drug Sensitivity Test And Study On Increasing Chemosensitivity On Pancreatic Cancer
57. Role And Mechanism Of Antisense Hypoxia-inducible Factor 1α In Pancreatic Cancer
58. A Study Of Integrin β1 Antisense Oligodeoxynucleotides On Pancreatic Cancer Therapy
59. The Effects Of AKT2 In The Pathogenesis Of Pancreatic Cancer
60. Experimental Research In Targeting Hypoxia-inducible Factor-1α For Pancreatic Cancer Therapy
  <<First  <Prev  Next>  Last>>  Jump to